Cargando…
A Theoretical Physiologically‐Based Pharmacokinetic Approach to Ascertain Covariates Explaining the Large Interpatient Variability in Tacrolimus Disposition
Physiologically‐based pharmacokinetic (PBPK) modeling allows assessment of the covariates contributing to the large pharmacokinetic (PK) variability of tacrolimus; these include multiple physiological and biochemical differences among patients. A PBPK model of tacrolimus was developed, including a v...
Autores principales: | Emoto, Chie, Johnson, Trevor N., Hahn, David, Christians, Uwe, Alloway, Rita R., Vinks, Alexander A., Fukuda, Tsuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539708/ https://www.ncbi.nlm.nih.gov/pubmed/30843669 http://dx.doi.org/10.1002/psp4.12392 |
Ejemplares similares
-
PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants
por: Emoto, Chie, et al.
Publicado: (2018) -
Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial
por: Alloway, Rita R., et al.
Publicado: (2017) -
Development of a Physiologically-Based Pharmacokinetic Model for Sirolimus: Predicting Bioavailability Based on Intestinal CYP3A Content
por: Emoto, C, et al.
Publicado: (2013) -
Characterizing the Developmental Trajectory of Sirolimus Clearance in Neonates and Infants
por: Emoto, C, et al.
Publicado: (2016) -
Using a Vancomycin PBPK Model in Special Populations to Elucidate Case‐Based Clinical PK Observations
por: Emoto, Chie, et al.
Publicado: (2018)